Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serial MRI and CSF biomarkers in normal aging, MCI, and AD.

Neurology - 13 Jul 2010

Vemuri P, Wiste H J, Weigand S D, Knopman D S, Trojanowski J Q, Shaw L M, Bernstein M A, Aisen P S, Weiner M, Petersen R C, Jack C R

Abstract excerpt

OBJECTIVE: To compare the annual change in MRI and CSF biomarkers in cognitively normal (CN), amnestic mild cognitive impairment (aMCI), and Alzheimer disease (AD). Comparisons were based on intergroup discrimination, correlation with concurrent cognitive/functional changes, relationships to APOE genotype, and sample sizes for clinical trials. METHODS: We used data from the Alzheimer's Disease Neuroimaging...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognition Disorders

Share to Neuropsychological Tests

Share to Peptide Fragments

Share to Reference Values

Share to Regression Analysis

Share to tau Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 20625167
DOI: 10.1212/WNL.0b013e3181e7ca82
PMCID: PMC2905929

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serial MRI and CSF biomarkers in normal aging, MCI, and AD.PMID 20625167Read ↗

Association of MRI-measured cerebral ventricular volume with APOE ε4 genotype, cerebrospinal fluid biomarkers (Aβ42 and Tau) and neuropsychological measures in Alzheimer’s disease: A Systematic ReviewSemantic proximity Read ↗

Patterns of progressive atrophy vary with age in Alzheimer's disease patients.Semantic proximity Read ↗

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.Semantic proximity Read ↗

Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.Semantic proximity Read ↗

Ventricular expansion, white matter hyperintensities, and global cognition in Alzheimer’s disease and normal agingSemantic proximity Read ↗

Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images.Semantic proximity Read ↗

Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkersSemantic proximity Read ↗

Biomarker Changes during 20 Years Preceding Alzheimer’s DiseaseSemantic proximity Read ↗

Alzheimer’s Disease Selectively Perturbs Age-Sensitive Brain Radiomic Features Across the Disease ContinuumSemantic proximity Read ↗

Prediction of clinical and biomarker conformed Alzheimer’s disease and mild cognitive impairment from multi-feature brain structural MRISemantic proximity Read ↗

Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.Semantic proximity Read ↗

Longitudinal subcortical volume changes and their correlations with multiple PET and fluid biomarkers in dominantly inherited Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.